Clinical Trials Logo

Filter by:
NCT ID: NCT04936477 Completed - Clinical trials for Bronchopulmonary Dysplasia

Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants

Start date: September 29, 2020
Phase: N/A
Study type: Interventional

To non-invasively estimate the alveolar surface area of the lungs of prematurely born infants by taking measurements of oxygen and carbon dioxide and utilizing functional morphometry.

NCT ID: NCT04936399 Completed - Clinical trials for Esophageal Squamous Cell Carcinoma

A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

Start date: June 25, 2020
Phase:
Study type: Observational

This purpose of this observational study is to review medical chart and patient survey data collection within an early access to medicines scheme (EAMS) program. Participant who are eligible, provide consent and enroll into the squamous cell oesophageal cancer EAMS to receive Nivolumab will be included in this study.

NCT ID: NCT04936022 Completed - Hypertension Clinical Trials

Isometric Exercise for People With Raised Blood Pressure

IsoFIT-BP
Start date: February 1, 2020
Phase: N/A
Study type: Interventional

High blood pressure affects many people in the United Kingdom. People with raised blood pressure (140-159/90-99 mmHg) are recommended to make changes in their lifestyle (e.g. smoking/alcohol/diet/exercise) and/or medication in order to reduce their blood pressure. Current knowledge suggests that a particular type of exercise - isometric exercise - can lower blood pressure. Isometric exercise involves holding a fixed body position for a short period of time. As most of the information about the benefits of this type of exercise comes from laboratory-based studies, researchers want to find out if it is possible for GP practices to offer NHS patients with clinically high blood pressure an isometric exercise plan to do at home and how it might affect their blood pressure over 6 months. They will also find out the experiences of those doing this type of exercise and whether it can be done consistently at home over time.

NCT ID: NCT04935905 Completed - Clinical trials for Neuromuscular Diseases

Accuracy of Peak Cough Flow Measurements Using a Mechanical Insufflator-exsufflator

MIEPCF
Start date: December 4, 2020
Phase:
Study type: Observational

The primary aim of this study is to evaluate the agreement of MIE devices measurement of MIE assisted peak cough flow (PCF) compared with a pneumotachographs during usual MIE care. This will be the first study to do this through range of MIE pressures and include patients who are receiving MIE via a tracheostomy. It will also aim to evaluate the intra-subject repeatability of measures for patients who receive more than one MIE cycle as part of their usual care. It will be the first to measure MIE assisted PCF contemporaneously during intervention using the gold standard pneumotachograph. This will inform treatment effect size and the efficacy of usual practice MIE in augmenting PCF measurements above critical cut off values for effective cough and secretion clearance. Finally the study will also aim to understand how patients perceive the impact of MIE in clearing secretions from their chest by asking them to rate presence of chest secretions pre and post intervention using a visual analogue scale (VAS)

NCT ID: NCT04935320 Completed - Healthy Subjects Clinical Trials

Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution

Start date: July 27, 2021
Phase: Phase 1
Study type: Interventional

This is a randomised, open-label, 3-period, crossover single dose study to assess the relative bioavailability of two formulations of HTL0016878: an oral solution of HCl salt form (the reference product) and an oral capsule containing citrate salt (the test product); and of the effect of food on the pharmacokinetics of the capsule formulation.

NCT ID: NCT04935099 Completed - Cognition Clinical Trials

The Effects of a Single Dose of Wild Blueberries on Mood and Cognition in Healthy Young Adults

Start date: May 26, 2021
Phase: N/A
Study type: Interventional

This study aims to investigate whether consuming a drink containing powdered blueberries (equivalent to 150 g fresh fruit) can improve mood and cognition in healthy young adults. Blood biomarkers of inflammation and neurotransmitter turnover will be analyzed as well as responses to computer-based cognitive tasks designed to measure verbal memory, executive function, and emotional processing.

NCT ID: NCT04935060 Completed - Dementia Clinical Trials

Sharing the Outcome of a Memory Assessment

Start date: September 21, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to establish the acceptability of a guide developed to improve people's experiences of dementia assessment outcome appointments in comparison to a standard consultation. This study will also inform the feasibility of future research evaluating the guide and provide information on how well the measurements used provide evaluation of the intervention.

NCT ID: NCT04932226 Completed - Clinical trials for Impact of Masks on Oxygen Levels

Face Masks and Oxygen Levels - What Happens During Exercise? (Masks in Exercise - a RandomIsed Trial)

MERIT
Start date: June 19, 2021
Phase: N/A
Study type: Interventional

The investigators aim to determine the effect of three different types of face mask compared to no face mask on the oxygen saturations, heart rate and symptoms of healthy young adults during 15 minutes of moderate to high intensity exercise. The three face masks will be a cloth mask, a surgical mask and a FFR.

NCT ID: NCT04931615 Completed - Breast Neoplasms Clinical Trials

ARTISS a Single-centre Randomised Control Study

ARTISS
Start date: February 1, 2022
Phase: Phase 4
Study type: Interventional

The Influence of ARTISS on post-operative abdominal drainage and seroma formation in DIEP/MS-TRAM free flap breast reconstruction patients.

NCT ID: NCT04931147 Completed - Inflammation Clinical Trials

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

Start date: May 13, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of RXC007.